Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Journal of Pharmaceutical and Biomedical Analysis|May 7, 2004
High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical productsJérôme Bouligand, Angelo Paci, Lionel Mercier, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 7, 2003
Contribution of high-performance thin-layer chromatography to a pharmaceutical quality assurance programme in a hospital chemotherapy manufacturing unitPhilippe Bourget, Angelo Paci, Jean Baptiste Rey, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2020
Pharmacokinetics/Pharmacodynamic (PK/PD) relationship of therapeutic monoclonal antibodies used in oncology: what's new?Olivier Mir, Sophie Broutin, Aude Desnoyer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 2, 2022
Quantification of succinic acid levels, linked to succinate dehydrogenase (SDH) dysfunctions, by an automated and fully validated liquid chromatography tandem mass spectrometry method suitable for multi-matrix applicationsConstance Lamy, Clémence Mansard, Louis Blondel, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 8, 2010
Oxazaphosphorines: new therapeutic strategies for an old class of drugsBérénice Giraud, Guillaume Hebert, Alain Deroussent, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 14, 2007
Simultaneous determination of gemcitabine and gemcitabine-squalene by liquid chromatography-tandem mass spectrometry in human plasmaHania Khoury, Alain Deroussent, L Harivardhan Reddy, et al.
British Journal of Cancer|July 22, 2016
Insights into significance of combined inhibition of MEK and m-TOR signalling output in KRAS mutant non-small-cell lung cancerSophie Broutin, Adam Stewart, Parames Thavasu, et al.
Journal for Immunotherapy of Cancer|August 14, 2020
Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effectsJulia Delahousse, Charles Skarbek, Mélanie Desbois, et al.
Journal of Pain and Symptom Management|June 24, 2010
Microbiological and physicochemical stability of oxycodone hydrochloride solutions for patient-controlled delivery systemsAhmed Amri, Ahmed Ben Achour, Elisabeth Chachaty, et al.
Bulletin Du Cancer|September 6, 2025
Pharmacogenetics in oncology: Unveiling its potential in treatment personalization and beyondVinh-Hoang-Lan Julie Tran, Angelo Paci, Tiphaine Adam de Beaumais, et al.
Pageof 11